Concentrations of the Stress Hormone Copeptin Increase upon Hypoglycaemia in Patients with Type 1 Diabetes Dependent of Hypoglycaemia Awareness

被引:12
|
作者
Seelig, Eleonora [1 ]
Bilz, Stefan [2 ]
Keller, Ulrich [1 ]
Meienberg, Fabian [1 ]
Christ-Crain, Mirjam [1 ]
机构
[1] Univ Basel Hosp, Dept Diabetol Endocrinol & Metab, CH-4031 Basel, Switzerland
[2] Kantonsspital, Dept Endocrinol, St Gallen, Switzerland
来源
PLOS ONE | 2013年 / 8卷 / 08期
关键词
INSULIN-INDUCED HYPOGLYCEMIA; ARGININE-VASOPRESSIN; STABLE PEPTIDE; PRECURSOR; PLASMA; SECRETION; RESPONSES; FAILURE; ASSAY;
D O I
10.1371/journal.pone.0072876
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: Copeptin, a marker for stress mirroring vasopressin concentrations, has been shown to increase upon insulin-induced hypoglycaemia in patients after transsphenoidal surgery of pituitary adenomas. Patients with type 1 diabetes mellitus are prone to hypoglycaemia, but no data about copeptin levels upon hypoglycaemia are available. Furthermore, the perception of hypoglycaemia can vary from total unawareness to disabling episodes. The aim of this study was to investigate whether copeptin increases upon hypoglycaemia in patients with type 1 diabetes mellitus and is associated with the degree of hypoglycaemia awareness. Materials and Methods: In this prospective observational study, 17 patients with type 1 diabetes underwent a standardized insulin infusion test. Blood sampling for glucose and copeptin was performed at baseline and after 60 minutes (min). To assess hypoglycaemia associated symptoms the Mood and Symptom Questionnaire (MSQ) was conducted at baseline and after 60 min. Results: During insulin infusion, blood glucose decreased from 5.1 (SD +/- 0.2) to 3.0 (+/- 0.5) mmol/L at 60 min (p<0.001). Copeptin concentrations increased from 3.2 (+/- 1.7) to 3.8 (+/- 1.9) pmol/L (p = 0.03). Mood and Symptoms Questionnaire scores increased from 14 (+/- 3.0) to 18 (+/- 5.8), (p = 0.006). Patients with good hypoglycaemia awareness had an increase in copeptin from 3.0 (+/- 1.8) to 4.2 (+/- 2.4) pmol/L (p = 0.03) in contrast to patients more unaware of hypoglycaemia who only showed an increase in copeptin from 3.3 (+/- 1.6) to 3.6 (+/- 1.4) pmol/L (p = 0.4). There was a trend to a larger copeptin increase in patients aware of hypoglycemia compared to patients unaware of hypoglycemia (p = 0.074). Conclusion: Copeptin increases in patients with type 1 diabetes upon insulin induced hypoglycaemia. Interestingly, the copeptin increase seems associated with the degree of hypoglycaemia awareness. This hypothesis warrants further verification.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Electrophysiological responses to hypoglycaemia in people with type 1 diabetes and impaired awareness of hypoglycaemia
    Novodvorsky, P.
    Bernjak, A.
    Smith, A.
    Downs, E.
    Arshad, M. F.
    Oprescu, A. I.
    Jacques, R. M.
    Lee, J.
    Ahmed, I.
    Heller, S. R.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S359 - S360
  • [2] Cerebral blood flow response to hypoglycaemia is altered in patients with type 1 diabetes and impaired awareness of hypoglycaemia
    Wiegers, E. C.
    Becker, K. M.
    Rooijackers, H. M.
    von Samson-Himmelstjerna, F. C.
    Tack, C. J.
    Heerschap, A.
    van der Graaf', M.
    de Galan, B. E.
    DIABETOLOGIA, 2016, 59 : S42 - S42
  • [3] Hypoglycaemia symptoms and impaired awareness of hypoglycaemia in adults with Type 1 diabetes: the association with diabetes duration
    Olsen, S. E.
    Asvold, B. O.
    Frier, B. M.
    Aune, S. E.
    Hansen, L. I.
    Bjorgaas, M. R.
    DIABETIC MEDICINE, 2014, 31 (10) : 1210 - 1217
  • [4] EFFECT OF THE GLP-1 RECEPTOR AGONIST EXENATIDE ON AWARENESS OF HYPOGLYCAEMIA IN PATIENTS WITH TYPE 1 DIABETES AND IMPAIRED AWARENESS OF HYPOGLYCAEMIA
    Van Meijel, L.
    Rooijackers, H. M.
    Tack, C. J.
    de Galan, B. E.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A132 - A133
  • [5] Fear of hypoglycaemia and its relation to hypoglycaemia awareness and symptom intensity in Type 1 diabetes
    Hatle, H.
    Bjorgaas, M. R.
    Ro, T. B.
    Olsen, S. E.
    Dsvold, B. O.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 137 : 213 - 220
  • [6] Frequency of symptomatic and asymptomatic hypoglycaemia in Type 1 diabetes: effect of impaired awareness of hypoglycaemia
    Schopman, J. E.
    Geddes, J.
    Frier, B. M.
    DIABETIC MEDICINE, 2011, 28 (03) : 352 - 355
  • [7] How to classify hypoglycaemia awareness in type 1 diabetes?
    Hoi-Hansen, T.
    Pedersen-Bjergaard, U.
    Thorsteinsson, B.
    DIABETOLOGIA, 2007, 50 : S336 - S336
  • [8] FLASH GLUCOSE MONITORING IMPROVES HYPOGLYCAEMIA AWARENESS AND REDUCES FEAR OF HYPOGLYCAEMIA IN ADULT PATIENTS WITH TYPE 1 DIABETES
    Laurenzi, A.
    Bongiorno, C.
    Caretto, A.
    Barrasso, M.
    Patti, L.
    Dozio, N.
    Scavini, M.
    Bosi, E.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A104 - A104
  • [9] Attitudes to awareness of hypoglycaemia tip the balance between hypoglycaemia fear and hyperglycaemia avoidance in problematic hypoglycaemia in type 1 diabetes
    Maclean, R.
    Jacob, P.
    Haywood, S.
    Choudhary, P.
    Heller, S.
    Toschi, E.
    Kariyawasam, D.
    Brooks, A.
    Rogers, H.
    Smith, E. L.
    Gonder-Frederick, L.
    de Zoysa, N.
    Amiel, S. A.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S358 - S358
  • [10] Frequency of biochemical and asymptomatic hypoglycaemia in people with Type 1 diabetes - with and without impaired awareness of hypoglycaemia
    Geddes, J.
    Wright, R. J.
    Zammitt, N. N.
    Frier, B. M.
    DIABETIC MEDICINE, 2008, 25